Pharma & Biotech

A dramatic power struggle is unfolding at ophthalmic device maker Staar Surgical, casting severe doubt over its pending acquisition by...

The pharmaceutical giant Teva is currently charting a remarkable recovery narrative. Having navigated years of consolidation and debt reduction, the...

Pharmaceutical titan Eli Lilly has delivered significant news on two distinct fronts, capturing investor attention. Beyond the intense spotlight on...

The disconnect between a company's operational performance and its stock market valuation is rarely as stark as the current situation...

Investors in Redcare Pharmacy are witnessing a severe disconnect. While the company's operational performance shows robust growth, its equity value...

The intersection of quantum computing and healthcare is drawing a skeptical eye from investors. IonQ, a leader in developing commercial...

ResMed's stock is experiencing notable selling pressure in today's trading session. This movement follows a significant shift in sentiment from...

A dramatic intraday sell-off in Assembly Biosciences shares, followed by a partial recovery, has highlighted a sharp divide in the...

Pharmaceutical titan Pfizer finds itself at a pivotal juncture. The era of spectacular pandemic-driven profits is receding, and the company...

Investors in Ocugen, a biotechnology firm focused on genetic treatments for rare eye diseases, were met with unsettling news in...